Yarrow Bioscience

Yahoo Finance • 2 months ago

VYNE Therapeutics GAAP EPS of -$2.14 misses by $1.92

* VYNE Therapeutics press release [https://seekingalpha.com/pr/20617851-yarrow-bioscience-reports-second-quarter-2026-financial-results-and-provides-business-update] (YARW [https://seekingalpha.com/symbol/YARW]): Q2 GAAP EPS of -$2.14 mi... Full story